Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Patients with central centrifugal cicatricial alopecia may have a higher risk of breast and colorectal cancer.

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

Cyclic nucleotide-gated channels are crucial for proper root hair growth and calcium balance in plants.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

HAIRCARECUBE TM (HCC) helps hair products work better by getting active ingredients deeper into the hair.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

CCC1 is crucial for pH balance in plant cells, affecting growth and stress tolerance.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Diagnosing and treating CCCA requires understanding multiple causes and using various diagnostic tools.

A new one-step test can quickly identify skin cancer during surgery.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

CCCA may involve the PD1/PDL1 pathway and increased caspase 3, leading to permanent hair loss.

Hair shaft malformation contributes to Central Centrifugal Cicatricial Alopecia.

The CTLA-4 gene polymorphism does not affect polycystic ovarian syndrome.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Cronkhite-Canada syndrome is a rare, non-inherited condition causing various symptoms like polyps, hair loss, and weight loss.

Hair loss in black women needs more research, early intervention, and community education.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

CTIP2 may help in skin development and maintenance.

Hair cortisol measurement can help diagnose and monitor Cushing’s disease.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

CCC1 is essential for pH balance and normal cell function in plants.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.